|
Volumn 98, Issue 2, 2013, Pages
|
Low-dose vemurafenib induces complete remission in a case of hairy-cell leukemia with a V600E mutation
|
Author keywords
Complete remission; Hairy cell leukemia; V600e mutation; Vemurafenib
|
Indexed keywords
B RAF KINASE;
CD103 ANTIGEN;
CD19 ANTIGEN;
HEMOGLOBIN;
VEMURAFENIB;
ANTINEOPLASTIC AGENT;
INDOLE DERIVATIVE;
PROTEIN KINASE INHIBITOR;
SULFONAMIDE;
AGED;
ANEMIA;
BONE MARROW BIOPSY;
CASE REPORT;
DRUG EFFICACY;
DYSPNEA;
FOLLOW UP;
GENE MUTATION;
HAIRY CELL LEUKEMIA;
HUMAN;
HUMAN TISSUE;
IMMUNOPHENOTYPING;
LETTER;
LOW DRUG DOSE;
NEUTROPENIA;
PYROSEQUENCING;
RELAPSE;
REMISSION;
THROMBOCYTE COUNT;
GENETICS;
LEUKEMIA, HAIRY CELL;
MUTATION;
TREATMENT OUTCOME;
ANTINEOPLASTIC AGENTS;
HUMANS;
INDOLES;
LEUKEMIA, HAIRY CELL;
MUTATION;
PROTEIN KINASE INHIBITORS;
PROTO-ONCOGENE PROTEINS B-RAF;
REMISSION INDUCTION;
SULFONAMIDES;
TREATMENT OUTCOME;
|
EID: 84875340204
PISSN: 03906078
EISSN: 15928721
Source Type: Journal
DOI: 10.3324/haematol.2012.082404 Document Type: Letter |
Times cited : (50)
|
References (5)
|